black cohosh
Botanicalexperimental
Actaea racemosa, the black cohosh, black bugbane, black snakeroot, rattle-top, or fairy candle, is a species of flowering plant of the family Ranunculaceae. It is native to eastern North America from the extreme south of Ontario to central Georgia, and west to Missouri and Arkansas. It grows in a variety of woodland habitats, and is often found in small woodland openings. — Wikipedia
Clinical trial activity
15 trials · 22 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
10
Phase 3
4
Phase 4
3
Earliest trial started Nov 1, 1998 (NCT02184364)
Timeline
Indications
Approved for
Studied for
- Anosmia · Phase 4
- Anxiety Disorders · Phase 4
- Breast Neoplasms · Phase 3
- Cough · Phase 4
- COVID-19 · Phase 4
- Fever · Phase 4
- Hot Flashes · Phase 3
- Menopause · Phase 4
- Myalgia · Phase 4
- Nasal Obstruction · Phase 4
- Nasopharyngitis · Phase 4
- Olfaction Disorders · Phase 4
- Osteoporosis, Postmenopausal · Phase 2
- Pharmacokinetics · Phase 2
- Postmenopause · Phase 2
- Quality of Life · Phase 3
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaActaea racemosa ↗
- NCATSK73E24S6X9 ↗
Also known as
- black cohosh
- black cohosh extract
- klimadynon
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04797936 | Phase 4 | May 1, 2020 | Ivano-Frankivsk National Medical University |
| NCT03461380 | Phase 2 | Sep 1, 2018 | EuroPharma, Inc., I.Zhordania Institute of Reproductology |
| NCT03339882 | Phase 2 | Jan 4, 2017 | Chinese Academy of Medical Sciences |
| NCT02952742 | Phase 2 | Nov 1, 2016 | Midwestern Regional Medical Center |
| NCT02093650 | Phase 3 | Mar 1, 2014 | Navamindradhiraj University, Vajira Hospital |
| NCT01628536 | N/A | Jun 1, 2012 | Yale University |
| NCT00120458 | Phase 4 | Jul 1, 2005 | National Center for Complementary and Integrative Health (NCCIH), Office of Dietary Supplements (ODS), University of Pennsylvania |
| NCT00299364 | Phase 3 | Sep 1, 2004 | Peking University, Schaper & Bruemmer GmbH & Co KG |
| NCT00060320 | Phase 3 | Oct 1, 2003 | Mayo Clinic, National Cancer Institute (NCI) |
| NCT00068185 | Phase 1 | Aug 1, 2003 | Duke University, National Center for Complementary and Integrative Health (NCCIH) |
| NCT00064831 | Phase 1/Phase 2 (Phase 2) | Jul 1, 2003 | National Center for Complementary and Integrative Health (NCCIH), University of Missouri |
| NCT00066144 | Phase 2 | Apr 1, 2003 | National Center for Complementary and Integrative Health (NCCIH), Office of Dietary Supplements (ODS), University of Illinois at Chicago |
| NCT00169299 | Phase 4 | Jun 1, 2001 | Group Health Cooperative, National Center for Complementary and Integrative Health (NCCIH), National Institute on Aging (NIA) |
| NCT00010712 | Phase 2 | Sep 1, 1999 | Columbia University, National Center for Complementary and Integrative Health (NCCIH) |
| NCT02184364 | Phase 3 | Nov 1, 1998 | Boehringer Ingelheim |
Showing 15 of 15 trials
Page 1 / 1
Organizations
Research & Development (22)
22 organizations
Page 1 / 2